Atlas Trials

Phase I Trial of LDE225 for Steroid-refractory Chronic GVHD After Allogeneic HSCT

Clinical trial NCT02086513 · TERMINATED

Trial details

NCT number
NCT02086513
Sponsor
Massachusetts General Hospital
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Graft Versus Host Disease
Start date
2014-04-01
Primary completion
2016-12-01
Enrollment
17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.